[1]ROTH G A,JOHNSON C,ABAJOBIR A,et al. Global,regional,and national burden of cardiovascular diseases for 10 causes,1990 to 2015[J]. J Am Coll Cardiol,2017,70(1):1-25. DOI:10.1016/j.jacc.2017.04.052.
[2]STURLAUGSDOTTIR R,ASPELUND T,BJORNSDOTTIR G,et al. Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study[J]. BMJ Open,2016,6(11):e012457. DOI:10.1136/bmjopen-2016-012457.
[3]YANEZ N D,BURKE G L,MANOLIO T,et al. Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly:the cardiovascular health study[J]. Ann Epidemiol,2009,19(12):858-866. DOI:10.1016/j.annepidem.2009.07.095.
[4]OOI Y C,GONZALEZ N R. Management of extracranial carotid artery disease[J]. Cardiol Clin,2015,33(1):1-35. DOI:10.1016/j.ccl.2014.09.001.
[5]STEFANADIS C,ANTONIOU C K,TSIACHRIS D,et al. Coronary atherosclerotic vulnerable plaque:current perspectives[J]. J Am Heart Assoc,2017,6(3):e005543. DOI:10.1161/JAHA.117.005543.
[6]SPACEK M,ZEMANEK D,HUTYRA M,et al. Vulnerable atherosclerotic plaque-a review of current concepts and advanced imaging[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2018,162(1):10-17. DOI:10.5507/bp.2018.004.
[7]NAGHAVI M,LIBBY P,FALK E,et al. From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part Ⅰ[J]. Circulation,2003,108(14):1664 -1672. DOI:10.1161/01.CIR.0000087480.94275.97.
[8]BERGHEANU S C,BODDE M C,JUKEMA J W. Pathophysiology and treatment of atherosclerosis[J]. Neth Heart J,2017,25(4):231-242. DOI:10.1007/s12471-017-0959-2.
[9]HAFIANE A. Vulnerable plaque,characteristics,detection,and potential therapies[J]. J Cardiovasc Dev Dis,2019,6(3):E26. DOI:10.3390/jcdd6030026.
[10]YONETSU T,JANG I K. Advances in intravascular imaging:new insights into the vulnerable plaque from imaging studies[J]. Korean Circ J,2018,48(1):1-15. DOI:10.4070/kcj.2017.0182.
[11]KRAMER M C,RITTERSMA S Z,DE WINTER R J,et al. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death[J]. J Am Coll Cardiol,2010,55(2):122-132. DOI:10.1016/j.jacc.2009.09.007.
[12]SABA L,YUAN C,HATSUKAMI T S,et al. Carotid artery wall imaging:perspective and guidelines from the ASNR vessel wall imaging study group and expert consensus recommendations of the American society of neuroradiology[J]. AJNR Am J Neuroradiol,2018,39(2):E9-31. DOI:10.3174/ajnr.A5488.
[13]DEMARCO J K,SPENCE J D. Plaque assessment in the management of patients with asymptomatic carotid Stenosis[J]. Neuroimaging Clin N Am,2016,26(1):111-127. DOI:10.1016/j.nic.2015.09.009.
[14]ABOYANS V,RICCO J B,BARTELINK M E L,et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases,in collaboration with the European Society for Vascular Surgery(ESVS):Document covering atherosclerotic disease of extracranial carotid and vertebral,mesenteric,renal,upper and lower extremity arteriesEndorsed by:the European Stroke Organization(ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology(ESC)and of the European Society for Vascular Surgery(ESVS)[J]. Eur Heart J,2018,39(9):763-816. DOI:10.1093/eurheartj/ehx095.
[15]JACOBSON T A,ITO M K,MAKI K C,et al. National Lipid Association recommendations for patient-centered management of dyslipidemia:part 1-executive summary[J]. J Clin Lipidol,2014,8(5):473-488. DOI:10.1016/j.jacl.2014.07.007.
[16]MACH F,BAIGENT C,CATAPANO A L,et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk[J]. Eur Heart J,2020,41(1):111-188. DOI:10.1093/eurheartj/ehz455.
[17]RAFAILIDIS V,LI X,SIDHU P S,et al. Contrast imaging ultrasound for the detection and characterization of carotid vulnerable plaque[J]. Cardiovasc Diagn Ther,2020,10(4):965-981. DOI:10.21037/cdt.2020.01.08.
[18]MURAKI M,MIKAMI T,YOSHIMOTO T,et al. New criteria for the sonographic diagnosis of a plaque ulcer in the extracranial carotid artery[J]. AJR Am J Roentgenol,2012,198(5):1161-1166. DOI:10.2214/AJR.11.7018.
[19]KANBER B,HARTSHORNE T C,HORSFIELD M A,et al. A novel ultrasound-based carotid plaque risk index associated with the presence of cerebrovascular symptoms[J]. Ultraschall Med,2015,36(5):480-486. DOI:10.1055/s-0034-1385462.
[20]KANBER B,HARTSHORNE T C,HORSFIELD M A,et al. Quantitative assessment of carotid plaque surface irregularities and correlation to cerebrovascular symptoms[J]. Cardiovasc Ultrasound,2013,11:38. DOI:10.1186/1476-7120-11-38.
[21]RAFAILIDIS V,HUANG D Y,YUSUF G T,et al. General principles and overview of vascular contrast-enhanced ultrasonography[J]. Ultrasonography,2020,39(1):22-42. DOI:10.14366/usg.19022.
[22]SCHMIDT C,FISCHER T,RüCKERT R I,et al. Identification of neovascularization by contrast-enhanced ultrasound to detect unstable carotid stenosis[J]. PLoS One,2017,12(4):e0175331. DOI:10.1371/journal.pone.0175331.
[23]TEN KATE G L,VAN DIJK A C,VAN DEN OORD S C,et al. Usefulness of contrast-enhanced ultrasound for detection of carotid plaque ulceration in patients with symptomatic carotid atherosclerosis[J]. Am J Cardiol,2013,112(2):292-298. DOI:10.1016/j.amjcard.2013.03.028.
[24]RAFAILIDIS V,CHRYSSOGONIDIS I,XERRAS C,et al. A comparative study of color Doppler imaging and contrast-enhanced ultrasound for the detection of ulceration in patients with carotid atherosclerotic disease[J]. Eur Radiol,2019,29(4):2137-2145. DOI:10.1007/s00330-018-5773-8.
[25]JOVANOVIC Z B,PAVLOVIC M A,VUJISIC TE?IC P B,et al. The significance of the ultrasound diagnostics in evaluation of the emboligenic pathogenesis of transient ischemic attacks[J]. Ultrasound Med Biol,2013,39(4):597-603. DOI:10.1016/j.ultrasmedbio.2012.10.015.
[26]ELIASZIW M,STREIFLER J Y,FOX A J,et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial[J]. Stroke,1994,25(2):304-308. DOI:10.1161/01.str.25.2.304.
[27]RAFAILIDIS V,CHARITANTI A,TEGOS T,et al. Swirling of microbubbles:demonstration of a new finding of carotid plaque ulceration on contrast-enhanced ultrasound explaining the arterio-arterial embolism mechanism[J]. Clin Hemorheol Microcirc,2016,64(2):245-250. DOI:10.3233/CH-16200.
[28]FAGGIOLI G L,PINI R,MAURO R,et al. Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography:correlation with plaque histology,symptoms and cerebral computed tomography[J]. Eur J Vasc Endovasc Surg,2011,41:238-248. DOI:10.1016/j.ejvs.2010.11.002.
[29]EKADIR K,GALIMZIANOVA A,BETRIU A,et al. A convolutional neural network for automatic characterization of plaque composition in carotid ultrasound[J]. IEEE J Biomed Health Inform,2017,21(1):48-55. DOI:10.1109/JBHI.2016.2631401.
[30]HEMMATI H,KAMLI-ASL A,TALEBPOUR A,et al. Semi-automatic 3D segmentation of carotid lumen in contrast-enhanced computed tomography angiography images[J]. Phys Med,2015,31(8):1098-1104. DOI:10.1016/j.ejmp.2015.08.002.
[31]TRELLES M,EBERHARDT K M,BUCHHOLZ M,et al. CTA for screening of complicated atherosclerotic carotid plaque--American Heart Association typeⅥ lesions as defined by MRI[J]. AJNR Am J Neuroradiol,2013,34(12):2331-2337. DOI:10.3174/ajnr.A3607.
[32]GUPTA A,BARADARAN H,KAMEL H,et al. Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis[J]. Stroke,2014,45(3):740-745. DOI:10.1161/STROKEAHA.113.003882.
[33]MURGIA A,ERTA M,SURI J S,et al. CT imaging features of carotid artery plaque vulnerability[J]. Ann Transl Med,2020,8(19):1261. DOI:10.21037/atm-2020-cass-13.
[34]DEMARCO J K,OTA H,UNDERHILL H R,et al. MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms:an in vivo study at 3T[J]. AJNR Am J Neuroradiol,2010,31(8):1395-1402. DOI:10.3174/ajnr.a2213.
[35]DAI Y Y,LV P,LIN J,et al. Comparison study between multicontrast atherosclerosis characterization(MATCH)and conventional multicontrast MRI of carotid plaque with histology validation[J]. J Magn Reson Imaging,2017,45(3):764-770. DOI:10.1002/jmri.25444.
[36]ZHANG Q,QIAO H Y,DOU J Q,et al. Plaque components segmentation in carotid artery on simultaneous non-contrast angiography and intraplaque hemorrhage imaging using machine learning[J]. Magn Reson Imaging,2019,60:93-100. DOI:10.1016/j.mri.2019.04.001.
[37]VIRMANI R,BURKE A P,KOLODGIE F D,et al. Vulnerable plaque:the pathology of unstable coronary lesions[J]. J Interv Cardiol,2002,15(6):439-446. DOI:10.1111/j.1540-8183.2002.tb01087.x.
[38]DEMARCO J K,OTA H,UNDERHILL H R,et al. MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms:an in vivo study at 3T[J]. AJNR Am J Neuroradiol,2010,31(8):1395-1402. DOI:10.3174/ajnr.a2213.
[39]SABA L,SAAM T,J?GER H R,et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications[J]. Lancet Neurol,2019,18(6):559-572. DOI:10.1016/S1474-4422(19)30035-3.
[40]SONG Y J,KWAK H S,CHUNG G H,et al. Quantification of carotid intraplaque hemorrhage:comparison between manual segmentation and semi-automatic segmentation on magnetization-prepared rapid acquisition with gradient-echo sequences[J]. Diagnostics(Basel),2019,9(4):E184. DOI:10.3390/diagnostics9040184.
[41]ZHU D C,VU A T,OTA H,et al. An optimized 3D spoiled gradient recalled echo pulse sequence for hemorrhage assessment using inversion recovery and multiple echoes(3D SHINE)for carotid plaque imaging[J]. Magn Reson Med,2010,64(5):1341-1351. DOI:10.1002/mrm.22517.
[42]WANG J,B?RNERT P,ZHAO H,et al. Simultaneous noncontrast angiography and intraplaque hemorrhage(SNAP)imaging for carotid atherosclerotic disease evaluation[J]. Magn Reson Med,2013,69(2):337-345. DOI:10.1002/mrm.24254.